Apr. 10 at 8:31 PM
$CTSO This is Chris Cramer's profile on LinkedIn.
Chief Executive Officer
HemoDefend · Full-time
Jan 2025 - Present · 1 yr 4 mos
Princeton, New Jersey, United States
As CEO of HemoDefend, I lead the spin-out and commercialization of HemoDefend-BGA, a first-in-class blood group antibody removal filter enabling universal plasma, platelets, whole blood, and plasma-processing applications across pre-hospital and hospital settings. My focus includes driving corporate strategy, fundraising, and investor relations; overseeing FDA De Novo and EU CE Mark regulatory pathways; shaping clinical plans and early health-economic evidence; and building operational readiness across manufacturing, supply chain, and quality systems. I also lead commercialization strategy for blood banks, trauma centers, military, and plasma processors while forging strategic partnerships across transfusion and trauma care. Through this work, I am positioning HemoDefend as a critical enabler of universal blood products...
